Evidence map›Paper›PMID 38396970›Full record

ArticleInternational journal of molecular sciences2024

CD163-Mediated Small-Vessel Injury in Alzheimer's Disease: An Exploration from Neuroimaging to Transcriptomics.

Yuewei Chen, Peiwen Lu, Shengju Wu, Jie Yang, Wanwan Liu, Alzheimer’s Disease Neuroimaging Initiative, Zhijun Zhang, Qun Xu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuewei ChenHealth Management Center, Renji Hospital of Medical School, Shanghai Jiao Tong University, Shanghai 200127, China.
Peiwen LuHealth Management Center, Renji Hospital of Medical School, Shanghai Jiao Tong University, Shanghai 200127, China.
Shengju WuSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China.
Jie YangHealth Management Center, Renji Hospital of Medical School, Shanghai Jiao Tong University, Shanghai 200127, China.
Wanwan LiuHealth Management Center, Renji Hospital of Medical School, Shanghai Jiao Tong University, Shanghai 200127, China.
Alzheimer’s Disease Neuroimaging Initiative
Zhijun ZhangSchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China.
Qun XuHealth Management Center, Renji Hospital of Medical School, Shanghai Jiao Tong University, Shanghai 200127, China.
Shanghai Jiao Tong University · CNRenji Hospital · CN

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
National Key R&D Program of China 2022YFA1603604 [ZZ]National Natural Science Foundation of China 82271320 [ZZ]NIA NIH HHS U01 AG024904Shanghai Science and Technology Committee Project Natural Science Funding; No. 23ZR1439200
6 · The paper itself

Abstract

Patients with Alzheimer's disease (AD) often present with imaging features indicative of small-vessel injury, among which, white-matter hyperintensities (WMHs) are the most prevalent. However, the underlying mechanism of the association between AD and small-vessel injury is still obscure. The aim of this study is to investigate the mechanism of small-vessel injury in AD. Differential gene expression analyses were conducted to identify the genes related to WMHs separately in mild cognitive impairment (MCI) and cognitively normal (CN) subjects from the ADNI database. The WMH-related genes identified in patients with MCI were considered to be associated with small-vessel injury in early AD. Functional enrichment analyses and a protein-protein interaction (PPI) network were performed to explore the pathway and hub genes related to the mechanism of small-vessel injury in MCI. Subsequently, the Boruta algorithm and support vector machine recursive feature elimination (SVM-RFE) algorithm were performed to identify feature-selection genes. Finally, the mechanism of small-vessel injury was analyzed in MCI from the immunological perspectives; the relationship of feature-selection genes with various immune cells and neuroimaging indices were also explored. Furthermore, 5×FAD mice were used to demonstrate the genes related to small-vessel injury. The results of the logistic regression analyses suggested that WMHs significantly contributed to MCI, the early stage of AD. A total of 276 genes were determined as WMH-related genes in patients with MCI, while 203 WMH-related genes were obtained in CN patients. Among them, only 15 genes overlapped and were thus identified as the crosstalk genes. By employing the Boruta and SVM-RFE algorithms, CD163, ALDH3B1, MIR22HG, DTX2, FOLR2, ALDH2, and ZNF23 were recognized as the feature-selection genes linked to small-vessel injury in MCI. After considering the results from the PPI network, CD163 was finally determined as the critical WMH-related gene in MCI. The expression of CD163 was correlated with fractional anisotropy (FA) values in regions that are vulnerable to small-vessel injury in AD. The immunostaining and RT-qPCR results from the verifying experiments demonstrated that the indicators of small-vessel injury presented in the cortical tissue of 5×FAD mice and related to the upregulation of CD163 expression. CD163 may be the most pivotal candidates related to small-vessel injury in early AD.

Indexed as

Alzheimer DiseaseAntigens, Differentiation, MyelomonocyticCognitive DysfunctionFolate Receptor 2White MatterAldehyde Dehydrogenase, MitochondrialAnimalsCD163 AntigenGene Expression ProfilingHumansMagnetic Resonance ImagingMiceNeuroimagingTranscription FactorsAldehyde Dehydrogenase, MitochondrialALDH2 protein, humanAntigens, Differentiation, MyelomonocyticCD163 AntigenFolate Receptor 2FOLR2 protein, humanTranscription FactorsZNF23 protein, humanAlzheimer’s diseaseCD163mild cognitive impairmenttranscriptomewhite-matter hyperintensities

Identifiers

PMID38396970
PMCPMC10888773
OpenAlexW4391823997

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.